85 related articles for article (PubMed ID: 158003)
1. [The facial mask as a basis of clindamycin therapy for acne vulgaris].
Gloor M; Bauer W
Hautarzt; 1979 Jul; 30(7):380-3. PubMed ID: 158003
[TBL] [Abstract][Full Text] [Related]
2. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
Tanghetti E; Dhawan S; Torok H; Kircik L
Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
[TBL] [Abstract][Full Text] [Related]
3. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study.
Marcinkiewicz J; Wojas-Pelc A; Walczewska M; Lipko-Godlewska S; Jachowicz R; Maciejewska A; Białecka A; Kasprowicz A
Eur J Dermatol; 2008; 18(4):433-9. PubMed ID: 18573718
[TBL] [Abstract][Full Text] [Related]
4. The safety and efficacy of clindamycin phosphate foam 1% versus clindamycin phosphate topical gel 1% for the treatment of acne vulgaris.
Shalita AR; Myers JA; Krochmal L; Yaroshinsky A;
J Drugs Dermatol; 2005; 4(1):48-56. PubMed ID: 15696985
[TBL] [Abstract][Full Text] [Related]
5. A multicenter clinical evaluation of the treatment of mild to moderate inflammatory acne vulgaris of the face with visible blue light in comparison to topical 1% clindamycin antibiotic solution.
Gold MH; Rao J; Goldman MP; Bridges TM; Bradshaw VL; Boring MM; Guider AN
J Drugs Dermatol; 2005; 4(1):64-70. PubMed ID: 15696987
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acne with topical antibiotics: lessons from clinical studies.
Simonart T; Dramaix M
Br J Dermatol; 2005 Aug; 153(2):395-403. PubMed ID: 16086756
[TBL] [Abstract][Full Text] [Related]
7. A new treatment for acne vulgaris combining benzoyl peroxide with clindamycin.
Tschen E; Jones T
J Drugs Dermatol; 2002 Sep; 1(2):153-7. PubMed ID: 12847739
[TBL] [Abstract][Full Text] [Related]
8. Results of a randomised, multicentre study comparing a new water-based gel of clindamycin 1% versus clindamycin 1% topical solution in the treatment of acne vulgaris.
Alirezaï M; Gerlach B; Horvath A; Forsea D; Briantais P; Guyomar M
Eur J Dermatol; 2005; 15(4):274-8. PubMed ID: 16048758
[TBL] [Abstract][Full Text] [Related]
9. Topical clindamycin formulations for the treatment of acne vulgaris. An evaluation.
McKenzie MW; Beck DC; Popovich NG
Arch Dermatol; 1981 Oct; 117(10):630-4. PubMed ID: 6456699
[TBL] [Abstract][Full Text] [Related]
10. A single centre, open-label, cross-over study of pharmacokinetics comparing topical zinc/clindamycin gel (Zindaclin) and topical clindamycin lotion (Dalacin T) in subjects with mild to moderate acne.
Chassard D; Kanis R; Namour F; Evene E; Ntssikoussalabongui B; Schmitz V
J Dermatolog Treat; 2006; 17(3):154-7. PubMed ID: 16854755
[TBL] [Abstract][Full Text] [Related]
11. [Topical treatment of acne vulgaris with erythromycin and benzoylperoxide (author's transl)].
Gloor M; Pfahler E; Neumann W; Höffler U; Hoffmann M; Schmidt U
Z Hautkr; 1982 Jun; 57(12):867-78. PubMed ID: 6214093
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of fixed low-dose isotretinoin (20 mg, alternate days) with topical clindamycin gel in moderately severe acne vulgaris.
Sardana K; Garg VK; Sehgal VN; Mahajan S; Bhushan P
J Eur Acad Dermatol Venereol; 2009 May; 23(5):556-60. PubMed ID: 19143903
[TBL] [Abstract][Full Text] [Related]
13. Topical clindamycin in acne vulgaris. Safety and stability.
Algra RJ; Rosen T; Waisman M
Arch Dermatol; 1977 Oct; 113(10):1390-1. PubMed ID: 143910
[TBL] [Abstract][Full Text] [Related]
14. Comparative evaluation of the efficacy of four topical medications individually or in combination to treat grade I acne vulgaris.
Biswas S; Mondal KK; Dutta RN; Sarkar DK
J Indian Med Assoc; 2009 Apr; 107(4):219-22. PubMed ID: 19810365
[TBL] [Abstract][Full Text] [Related]
15. Tazarotene versus tazarotene plus clindamycin/benzoyl peroxide in the treatment of acne vulgaris: a multicenter, double-blind, randomized parallel-group trial.
Tanghetti E; Abramovits W; Solomon B; Loven K; Shalita A
J Drugs Dermatol; 2006 Mar; 5(3):256-61. PubMed ID: 16573259
[TBL] [Abstract][Full Text] [Related]
16. Double-blind comparison of topical 1 percent clindamycin phosphate (Cleocin T) and oral tetracycline 500 mg/day in the treatment of acne vulgaris.
Stoughton RB; Cornell RC; Gange RW; Walter JF
Cutis; 1980 Oct; 26(4):424-5, 429. PubMed ID: 6448131
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of oral isotretinoin in the control of skin and nasal colonization by antibiotic-resistant propionibacteria in patients with acne.
Coates P; Vyakrnam S; Ravenscroft JC; Stables GI; Cunliffe WJ; Leyden JJ; Johnson J; Eady EA; Cove JH
Br J Dermatol; 2005 Dec; 153(6):1126-36. PubMed ID: 16307647
[TBL] [Abstract][Full Text] [Related]
18. Effects of treatment with erythromycin 1.5 percent topical solution or clindamycin phosphate 1.0 percent topical solution on P. acnes counts and free fatty acid levels.
Puhvel SM
Cutis; 1983 Mar; 31(3):339-42. PubMed ID: 6220870
[TBL] [Abstract][Full Text] [Related]
19. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR
J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
[TBL] [Abstract][Full Text] [Related]
20. Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study.
Bowman S; Gold M; Nasir A; Vamvakias G
J Drugs Dermatol; 2005; 4(5):611-8. PubMed ID: 16167420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
